U.S. Capital Wealth Advisors’s State Street SPDR S&P Pharmaceuticals ETF XPH Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$764K	Sell	14,133 -299	-2%	-$16.7K	0.02%	579
2025 Q4	$808K	Sell	14,432 -298	-2%	-$15.4K	0.02%	539
2025 Q3	$706K	Buy	14,730 +378	+3%	+$16.9K	0.02%	545
2025 Q2	$582K	Sell	14,352 -350	-2%	-$14.1K	0.02%	563
2025 Q1	$644K	Sell	14,702 -5,008	-25%	-$221K	0.02%	525
2024 Q4	$847K	Sell	19,710 -2,620	-12%	-$119K	0.03%	451
2024 Q3	$991K	Buy	22,330 +4,264	+24%	+$183K	0.03%	354
2024 Q2	$719K	Buy	18,066 +5,531	+44%	+$224K	0.03%	389
2024 Q1	$541K	Buy	12,535 +635	+5%	+$27.4K	0.02%	454
2023 Q4	$495K	Buy	+11,900	New	+$451K	0.02%	455
2023 Q1	–	Sell	-1,100	Closed	-$45K	–	1552
2022 Q4	$45K	Buy	+1,100	New	+$45.8K	﹤0.01%	912